Letter by Zhao Regarding Article, “Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial”

Circulation 2026

View at publisher

Authors: Yun-Tao Zhao

DOI: 10.1161/circulationaha.125.076451

Cited by: 0

References: 1

Fields of Study & Subjects

Diabetes Treatment and Management Heart Failure Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins

References 1